These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1819 related articles for article (PubMed ID: 32296030)

  • 21. Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents.
    Zhou HM; Zhang JG; Zhang X; Li Q
    Signal Transduct Target Ther; 2021 Feb; 6(1):62. PubMed ID: 33589595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural Products That Target Cancer Stem Cells.
    Moselhy J; Srinivasan S; Ankem MK; Damodaran C
    Anticancer Res; 2015 Nov; 35(11):5773-88. PubMed ID: 26503998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment.
    Islam F; Gopalan V; Smith RA; Lam AK
    Exp Cell Res; 2015 Jul; 335(1):135-47. PubMed ID: 25967525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.
    Garner JM; Fan M; Yang CH; Du Z; Sims M; Davidoff AM; Pfeffer LM
    J Biol Chem; 2013 Sep; 288(36):26167-26176. PubMed ID: 23902772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
    Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
    J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies.
    Khan AQ; Ahmed EI; Elareer NR; Junejo K; Steinhoff M; Uddin S
    Cells; 2019 Aug; 8(8):. PubMed ID: 31530793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer stem cells: A review of their characteristics and the agents that affect them.
    Shan NL; Shin Y; Yang G; Furmanski P; Suh N
    Mol Carcinog; 2021 Feb; 60(2):73-100. PubMed ID: 33428807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-CSCs nourish CSCs through interleukin-17E-mediated activation of NF-κB and JAK/STAT3 signaling in human hepatocellular carcinoma.
    Luo Y; Yang Z; Su L; Shan J; Xu H; Xu Y; Liu L; Zhu W; Chen X; Liu C; Chen J; Yao C; Cheng F; Zhang C; Ma Q; Shen J; Qian C
    Cancer Lett; 2016 Jun; 375(2):390-399. PubMed ID: 27000993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between telomerase and mTOR pathway in cancer stem cells.
    Dogan F; Biray Avci C
    Gene; 2018 Jan; 641():235-239. PubMed ID: 29074462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NF-κB signaling in cancer stem cells: a promising therapeutic target?
    Vazquez-Santillan K; Melendez-Zajgla J; Jimenez-Hernandez L; Martínez-Ruiz G; Maldonado V
    Cell Oncol (Dordr); 2015 Oct; 38(5):327-39. PubMed ID: 26318853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA.
    Zhang Y; Lapidus RG; Liu P; Choi EY; Adediran S; Hussain A; Wang X; Liu X; Dan HC
    Mol Cancer Ther; 2016 Jul; 15(7):1504-14. PubMed ID: 27196761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salinomycin as a drug for targeting human cancer stem cells.
    Naujokat C; Steinhart R
    J Biomed Biotechnol; 2012; 2012():950658. PubMed ID: 23251084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
    Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
    J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells.
    Hajizadeh F; Okoye I; Esmaily M; Ghasemi Chaleshtari M; Masjedi A; Azizi G; Irandoust M; Ghalamfarsa G; Jadidi-Niaragh F
    Life Sci; 2019 Nov; 237():116952. PubMed ID: 31622608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.
    Takebe N; Harris PJ; Warren RQ; Ivy SP
    Nat Rev Clin Oncol; 2011 Feb; 8(2):97-106. PubMed ID: 21151206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. JAK/STAT3 and NF-κB Signaling Pathways Regulate Cancer Stem-Cell Properties in Anaplastic Thyroid Cancer Cells.
    Shiraiwa K; Matsuse M; Nakazawa Y; Ogi T; Suzuki K; Saenko V; Xu S; Umezawa K; Yamashita S; Tsukamoto K; Mitsutake N
    Thyroid; 2019 May; 29(5):674-682. PubMed ID: 30784360
    [No Abstract]   [Full Text] [Related]  

  • 38. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics.
    Borlongan MC; Wang H
    Front Cell Dev Biol; 2023; 11():1125174. PubMed ID: 37305676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.
    Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW
    J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 91.